FR2146295B1 - - Google Patents
Info
- Publication number
- FR2146295B1 FR2146295B1 FR7225621A FR7225621A FR2146295B1 FR 2146295 B1 FR2146295 B1 FR 2146295B1 FR 7225621 A FR7225621 A FR 7225621A FR 7225621 A FR7225621 A FR 7225621A FR 2146295 B1 FR2146295 B1 FR 2146295B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
- C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
- C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
- C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
- C07H15/236—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2 a saccharide radical being substituted by an alkylamino radical in position 3 and by two substituents different from hydrogen in position 4, e.g. gentamicin complex, sisomicin, verdamycin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3358371A GB1364521A (en) | 1971-07-16 | 1971-07-16 | Aminoglycoside antibiotics |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2146295A1 FR2146295A1 (de) | 1973-03-02 |
FR2146295B1 true FR2146295B1 (de) | 1976-05-14 |
Family
ID=10354806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7225621A Expired FR2146295B1 (de) | 1971-07-16 | 1972-07-13 |
Country Status (4)
Country | Link |
---|---|
DE (1) | DE2234804A1 (de) |
FR (1) | FR2146295B1 (de) |
GB (1) | GB1364521A (de) |
NL (1) | NL7209320A (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4396609A (en) * | 1975-02-18 | 1983-08-02 | Sterling Drug Inc. | Aminocyclitol antibiotics, pharmaceutical compositions and method of using same |
US7345018B2 (en) | 2002-04-25 | 2008-03-18 | Reception Aps | Method of treating side effects induced by therapeutic agents |
AU2004224788A1 (en) * | 2003-03-26 | 2004-10-07 | Recepticon Aps | Use of compounds for the prevention of drug-induced cell toxicity |
-
1971
- 1971-07-16 GB GB3358371A patent/GB1364521A/en not_active Expired
-
1972
- 1972-07-03 NL NL7209320A patent/NL7209320A/xx unknown
- 1972-07-13 FR FR7225621A patent/FR2146295B1/fr not_active Expired
- 1972-07-14 DE DE19722234804 patent/DE2234804A1/de active Pending
Also Published As
Publication number | Publication date |
---|---|
GB1364521A (en) | 1974-08-21 |
NL7209320A (de) | 1973-01-18 |
FR2146295A1 (de) | 1973-03-02 |
DE2234804A1 (de) | 1973-01-25 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |